Comparison of whole-cell versus acellular pertussis vaccine effectiveness in school clusters of pertussis, France, 2013 - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Médecine et Maladies Infectieuses Année : 2020

Comparison of whole-cell versus acellular pertussis vaccine effectiveness in school clusters of pertussis, France, 2013

Résumé

Objectives and method.-We conducted a prospective study in 2013 to compare the whole-cell versus acellular pertussis vaccines effectiveness and duration of protection, following the occurrence of pertussis clusters. Results.-During seven school outbreaks, we identified 102 clinical pertussis cases, including 10 cases biologically confirmed by Bordetella pertussis specific PCR, among a cohort of 305 children in 2nd to 6th grade. The risk of pertussis when vaccinated with an acellular vaccine alone was 1.6 (RR = 1.6; 95% CI = 1.1-2.5) times higher than when vaccinated with a whole-cell vaccine or using a combined schedule. Conclusions.-The limited duration of protection conferred by the acellular vaccine reinforces the 2013 introduction of the pertussis booster at six years old.
Fichier non déposé

Dates et versions

pasteur-03257292 , version 1 (10-06-2021)

Identifiants

Citer

Emmanuel Belchior, Sophie Guillot, I. Poujol, A. Thabuis, L. Chouin, et al.. Comparison of whole-cell versus acellular pertussis vaccine effectiveness in school clusters of pertussis, France, 2013. Médecine et Maladies Infectieuses, 2020, 50 (7), pp.617 - 619. ⟨10.1016/j.medmal.2020.07.004⟩. ⟨pasteur-03257292⟩

Collections

PASTEUR
17 Consultations
3 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More